Last reviewed · How we verify
probiotic ® pur
Probiotic PUR restores beneficial gut microbiota to improve intestinal barrier function and modulate immune responses.
Probiotic PUR restores beneficial gut microbiota to improve intestinal barrier function and modulate immune responses. Used for Gastrointestinal disorders associated with dysbiosis.
At a glance
| Generic name | probiotic ® pur |
|---|---|
| Sponsor | Yuzuncu Yil University |
| Drug class | Probiotic |
| Modality | Small molecule |
| Therapeutic area | Gastroenterology / Immunology |
| Phase | Phase 3 |
Mechanism of action
This probiotic formulation contains live beneficial bacteria that colonize the gastrointestinal tract, enhancing the intestinal epithelial barrier, reducing pathogenic bacterial overgrowth, and promoting a balanced microbiome. By restoring eubiotic conditions, it may enhance mucosal immunity and reduce systemic inflammation through microbial metabolite production and immune tolerance mechanisms.
Approved indications
- Gastrointestinal disorders associated with dysbiosis
Common side effects
- Gastrointestinal disturbance (bloating, gas)
- Mild abdominal discomfort
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- probiotic ® pur CI brief — competitive landscape report
- probiotic ® pur updates RSS · CI watch RSS
- Yuzuncu Yil University portfolio CI